Fetal exposure to propoxur and abnormal child neurodevelopment at 2 years of age

Enrique M Ostrea1, Alexis Reyes, Esterlita Villanueva-Uy

  • 1Department of Pediatrics, Hutzel Women's Hospital, the Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Wayne State University, Detroit, MI, United States. eostrea@med.wayne.edu

Neurotoxicology
|December 14, 2011
PubMed

Insights

Prenatal exposure to the pesticide propoxur is linked to poorer motor development in children by age two. This study investigated pesticide effects on neurodevelopment in a Philippine cohort.

Area of Science:

  • Environmental Health
  • Neurodevelopmental Toxicology
  • Pediatric Epidemiology

Background:

  • Pesticide use is widespread in agricultural regions, raising concerns about potential neurodevelopmental impacts.
  • Prenatal exposure to environmental toxins can affect child development.
  • Limited data exists on the specific effects of propoxur and pyrethroids on early neurodevelopment.

Purpose of the Study:

  • To assess the association between fetal exposure to propoxur and pyrethroids and neurodevelopmental outcomes in children at two years of age.
  • To identify sensitive biomarkers for detecting prenatal pesticide exposure.

Main Methods:

  • Prospective cohort study in the Philippines with maternal recruitment during pregnancy.
  • Analysis of maternal and infant biological samples (hair, blood, meconium) for pesticide detection using gas chromatography/mass spectrometry.
  • Neurodevelopmental assessment of children at two years using the Griffiths Mental Developmental Scale.

Main Results:

  • Meconium analysis proved most sensitive for detecting fetal pesticide exposure.
  • Prenatal exposure to propoxur was significantly associated with poorer motor development at 24 months (β=-0.14, p<0.001) after controlling for confounders.
  • Higher exposure rates were observed for propoxur and grouped pyrethroids.

Conclusions:

  • Prenatal exposure to propoxur is associated with adverse motor development in children by two years of age.
  • Findings highlight the potential neurotoxic effects of common pesticides on child development.
  • Meconium is a valuable matrix for assessing prenatal pesticide exposure.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...